Nalmefene vs placebo to reduce cravings in behavioral addictions
Part of Mental health clinical trials.
This study tests whether nalmefene, a non-opioid medicine, can reduce craving episodes in people with behavioral addictions like gambling, food addiction, or sexual addiction. Participants keep tracking cravings weekly, and compare the nalmefene effect against a placebo in addition to their usual care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older, and you can give written informed consent
- You are currently being treated (or starting care) for gambling, food addiction, or sexual addiction at an addiction clinic
- You can reliably fill out a weekly diary to report your craving episodes
- In the week before joining, you had at least one craving episode with intensity 4 out of 10 or higher
- You are able to take study medicine at the time of day when your craving is usually most intense
- You are on the French social security system (or covered by it)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new implant form of the medicine nalmefene to see if it is safe and well-tolerated in healthy adults. It is an early-phase study that helps researchers understand how the body reacts to the implant before testing it in people with opioid use problems.
This trial is testing if taking cannabidiol (CBD) plus naltrexone can reduce alcohol craving in people with alcohol dependence. Naltrexone is already used to help with alcohol cravings, and CBD may add extra benefit.
This study tests whether a medication called naltrexone can help reduce the urge or behavior of self-injury (hurting yourself on purpose) in people who have not improved with standard treatment. It may offer a new option to manage these urges.
This trial is a longitudinal study that tracks how cravings (strong urges to use) affect a person's addiction over time. It may help researchers understand how cravings lead to more severe addiction, which could improve future treatments.
This study looks at whether craving—a strong urge—should be a main symptom for diagnosing behavioral addictions like gambling, gaming, overeating, excessive screen use, or sex/pornography addiction. If you regularly do one of these behaviors, your experiences could help researchers improve how addictions are diagnosed.
This study tests whether the medication naltrexone can help reduce self-harm urges or actions in people who hurt themselves without intending suicide. It may offer a new option if current treatments haven't been enough.
Hear when a new Behavioural Addiction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.